KemPharm Inc KMPH:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 06/18/21 EDT
13.90quote price arrow down-0.03 (-0.22%)
Volume
3,630
Close
13.93quote price arrow down-1.54 (-9.95%)
Volume
3,173,468
52 week range
3.84 - 22.08

...

Loading . . .
  • Open15.15
  • Day High15.21
  • Day Low13.11
  • Prev Close15.47
  • 52 Week High22.08
  • 52 Week High Date11/24/20
  • 52 Week Low3.84
  • 52 Week Low Date07/09/20

Key Stats

  • Market Cap397.14M
  • Shares Out28.51M
  • 10 Day Average Volume1.19M
  • Dividend-
  • Dividend Yield-
  • Beta3.28
  • YTD % Change24.38

KEY STATS

  • Open15.15
  • Day High15.21
  • Day Low13.11
  • Prev Close15.47
  • 52 Week High22.08
  • 52 Week High Date11/24/20
  • 52 Week Low3.84
  • 52 Week Low Date07/09/20
  • Market Cap397.14M
  • Shares Out28.51M
  • 10 Day Average Volume1.19M
  • Dividend-
  • Dividend Yield-
  • Beta3.28
  • YTD % Change24.38

RATIOS/PROFITABILITY

  • EPS (TTM)-4.03
  • P/E (TTM)-3.46
  • Fwd P/E (NTM)-185.73
  • EBITDA (MRQ)5.389M
  • ROE (MRQ)-702.95%
  • Revenue (MRQ)23.32M
  • Gross Margin (MRQ)47.92%
  • Net Margin (MRQ)-74.21%
  • Debt To Equity (MRQ)1.08%

EVENTS

  • Earnings Date08/10/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On KemPharm Inc

There is no recent news for this security.

Profile

MORE
KemPharm, Inc. is a clinical-stage specialty pharmaceutical company. The Company is engaged in the discovery and development of prodrugs. The Company uses its Ligand Activated Therapy (LAT) platform technology to create prodrugs. The Company's product candidate, KP201/APAP, consists of KP201, its prodrug of hydrocodone, which is combined with acetaminophen (APAP). The Company is developing KP201/APAP as an immediate release (IR), a product candidate for the short-term, or no...
Travis Mickle Ph.D.
Chairman
R. LaDuane Clifton CPA
Chief Financial Officer
Sven Guenther Ph.D.
Executive Vice President
Timothy Sangiovanni
Vice President
Address
1180 Celebration Blvd Ste 103
Celebration, FL
34747-4950
United States

Top Peers

SYMBOLLASTCHG%CHG
URGN
Urogen Pharma Ltd
16.45-0.33-1.97%
HARP
Harpoon Therapeutics Inc
15.02-0.36-2.34%
SYRS
Syros Pharmaceuticals Inc
5.62UNCHUNCH
XOMA
XOMA Corp
30.41-0.40-1.30%
SPRO
Spero Therapeutics Inc
14.67-0.50-3.30%